您的购物车当前为空
别名 FY-26, FY 26
FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer activity, and most remarkably, it improves the selectivity for cancer cells versus normal fibroblasts.

FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer activity, and most remarkably, it improves the selectivity for cancer cells versus normal fibroblasts.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 待询 |
| 产品描述 | FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer activity, and most remarkably, it improves the selectivity for cancer cells versus normal fibroblasts. |
| 别名 | FY-26, FY 26 |
| 分子量 | 822.6 |
| 分子式 | C23H28F6IN4OsP |
| CAS No. | 1255143-82-8 |
| Smiles | [Os++]123456([#6;v5]-7=[C]1([#6])[#6;v5]2=[#6;v5]3[C]4(=[#6;v5]5-7)[#6](-[#6])-[#6])([#7](=[#7]-[#6]-1=[#7]6-[#6]=[#6]-[#6]=[#6]-1)-c1ccc(cc1)-[#7](-[#6])-[#6])[I-].[P+5]([F-])([F-])([F-])([F-])([F-])[F-] |c:6,17,19,22,24,^1:11,14,28| |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多